Results
1 -
2 of
2
(Click
here to explore results)
- Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain. Samuel D. Banister, Kaavya Krishna Kumar, Vineet Kumar, Brian K. Kobilka, Sanjay V. Malhotra
, Med. Chem. Commun.
, 2019
, 10
, 647
- Cutting edge of diphenyl phosphorazidate (DPPA) as a synthetic reagent – A fifty-year odyssey. Takayuki Shioiri, Kotaro Ishihara, Masato Matsugi
, Org. Chem. Front.
, 2022
, 9
, 3360